Acalypha (Acalypha indica)

Acalypha indica is a medicinal plant used in traditional Siddha medicine containing bioactive compounds like alkaloids and flavonoids that demonstrate neuroprotective and anti-inflammatory properties. Research shows it may reduce Parkinsonian symptoms and asthmatic inflammation through modulation of dopaminergic pathways and immune responses.

Origin & History

Acalypha indica is a herbaceous plant from the Euphorbiaceae family, widely distributed in tropical and warmer regions worldwide. The supplement is sourced from the leaves and aerial parts of the plant, with extracts typically prepared using solvents such as ethanol, petroleum ether, or water, followed by fractionation and analysis via techniques like HPTLC or GC-MS.

Historical & Cultural Context

Acalypha indica has been used globally in traditional medicine systems, particularly in ethnobotanical practices across tropical regions for ailments like asthma, inflammation, skin disorders, and infections. Historical applications span various indigenous systems, with some traditional uses now showing validation in preclinical models (PMIDs: 35149129, 37236382).

Health Benefits

• Anti-Parkinsonian effects: Reduced anxiety behaviors and improved motor coordination in MPTP-induced mouse models at 100-400 mg/kg doses (preliminary animal evidence, PMID: 40694653)
• Anti-asthmatic activity: Reduced leucocytosis, eosinophilia, and mast cell degranulation in multiple rodent models (preliminary animal evidence, PMID: 35149129)
• Psoriasis management: Topical application reduced psoriasis-like symptoms in imiquimod-induced mouse models (preliminary animal evidence, PMID: 37236382)
• Antimicrobial effects: Demonstrated antibacterial and antibiofilm activity against S. aureus and E. coli in vitro (preliminary in vitro evidence)
• Anti-inflammatory properties: Showed protein denaturation inhibition and HRBC membrane stabilization in vitro assays (preliminary in vitro evidence, PMID: 37796311)

How It Works

Acalypha indica's alkaloids and flavonoids appear to protect dopaminergic neurons from MPTP-induced damage by reducing oxidative stress and neuroinflammation. The plant's anti-asthmatic effects involve inhibition of mast cell degranulation and reduction of eosinophilia, suggesting histamine pathway modulation. These mechanisms likely involve antioxidant enzyme upregulation and inflammatory cytokine suppression.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Acalypha indica; all evidence is limited to preclinical animal, in vitro, or in silico studies. Key preclinical studies include MPTP-induced Parkinson's disease mouse models (PMID: 40694653), anti-asthmatic effects in rodent models (PMID: 35149129), and topical application in psoriasis mouse models (PMID: 37236382).

Clinical Summary

Current evidence for Acalypha indica comes primarily from animal studies rather than human clinical trials. In MPTP-induced Parkinson's mouse models, doses of 100-400 mg/kg showed reduced anxiety behaviors and improved motor coordination. Multiple rodent studies demonstrated anti-asthmatic activity with decreased leucocytosis, eosinophilia, and mast cell degranulation. Human clinical data is lacking, limiting the strength of evidence for therapeutic applications.

Nutritional Profile

Acalypha indica (Indian copperleaf) nutritional and phytochemical composition is characterized primarily by bioactive compounds rather than conventional macronutrients, as it is used medicinally rather than as a staple food. Known constituents include: ALKALOIDS: acalyphine (principal alkaloid, ~0.1-0.3% dry weight), aurantiamide acetate, and cyanogenic glycosides; FLAVONOIDS: kaempferol, quercetin, and rutin identified via HPLC analysis in leaf extracts; TANNINS: hydrolysable and condensed tannins (~4-8% dry weight in leaves); SAPONINS: triterpenoid saponins detected in aerial parts; STEROLS: beta-sitosterol and stigmasterol in leaf and root fractions; PHENOLIC ACIDS: gallic acid, ellagic acid, and chlorogenic acid contributing to total phenolic content of approximately 15-25 mg GAE/g dry extract; ESSENTIAL OILS: trace volatile compounds including caryophyllene and limonene in aerial parts; PROTEINS: crude protein approximately 15-20% dry weight in leaves (limited quantitative data); FIBER: crude fiber approximately 8-12% dry weight; MINERALS: iron, calcium, and potassium detected qualitatively, with iron content noted as relatively elevated compared to common leafy vegetables (specific mg/100g data lacking in peer-reviewed literature); BIOAVAILABILITY NOTE: Alkaloid and flavonoid absorption is moderate; tannin content may reduce mineral bioavailability via chelation; aqueous and ethanolic extracts show differential bioactive compound yields, with 70% ethanol extracts yielding higher phenolic concentrations than water decoctions.

Preparation & Dosage

No clinically studied dosages in humans are available. Preclinical studies used oral doses of 100-400 mg/kg extract in mice and topical applications at unspecified concentrations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Gallic acid, Catechin, Kaempferol, Green tea extract, Quercetin

Safety & Interactions

Safety data for Acalypha indica in humans is limited due to lack of clinical trials. Traditional use suggests general tolerability, but potential side effects, optimal dosing, and long-term safety remain unstudied. Drug interactions are unknown and should be considered, particularly with Parkinson's medications or asthma treatments. Pregnant and nursing women should avoid use due to insufficient safety data.